new glp-1 drug retatrutide Retatrutide, an experimental weight-loss drug, has not been approved by the FDA. But, doctors and nurse practitioners in clinics across the country are prescribing it anyway, a CBS News investigation Retatrutide Triple Agonist Peptide |

Description

Exp Mol Pathol 107:124128 Faurschou A et al (2013) Increased expression of glucagon-like peptide-1 receptors in psoriasis plaques

GLP-1s: cost, coverage, and access Costs for GLP-1 medications like semaglutide and tirzepatide can differ widely, and what you pay will depend on factors such as whether or not you have insurance and if these medications are included in your plan

Weight Loss Potential: Minimal, usually around 5 to 11 pounds

doi: 10.1001/jama.2017.6803

Targets healthy metabolic function using plant-derived compounds* Supports digestive wellness and gut balance* Enhances nutrient absorption and herbal synergy through piperine* Designed for consistent daily use with cumulative wellness benefits* *These statements have not been evaluated by the Food and Drug Administration